Lanier Biotherapeutics
Biotechnology, 150 Ben Burton Rd, Bogart, Georgia, 30622, United States, 1-10 Employees
Phone Number: +12*********
Who is LANIER BIOTHERAPEUTICS
Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the ul...
Read More
-
Headquarters: 150 Ben Burton Rd, Bogart, Georgia, 30622, United States
-
Employees: 1-10
-
Revenue: $5 Million to $10 Million
-
CEO:
Daniel White
Email
Phone
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from LANIER BIOTHERAPEUTICS
Lanier Biotherapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Lanier Biotherapeutics
Answer: Lanier Biotherapeutics's headquarters are located at 150 Ben Burton Rd, Bogart, Georgia, 30622, United States
Answer: Lanier Biotherapeutics's phone number is +12*********
Answer: Lanier Biotherapeutics's official website is https://lanierbio.com
Answer: Lanier Biotherapeutics's revenue is $5 Million to $10 Million
Answer: Lanier Biotherapeutics's SIC: 2834
Answer: Lanier Biotherapeutics's NAICS: 325412
Answer: Lanier Biotherapeutics has 1-10 employees
Answer: Lanier Biotherapeutics is in Biotechnology
Answer: Lanier Biotherapeutics contact info: Phone number: +12********* Website: https://lanierbio.com
Answer: Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the ultimate goal of improving the way we survive, age, and live. Lanier targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology. Laniers lead developments programs include LNR 653.1, a fully humanized anti-VEGF / IL-17A multifunctional antibody for the treatment of retinal neovascularization diseases and LNR 125.36, a fully humanized anti-IL-25 monoclonal antibody for the treatment of Type 2 Inflammatory diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month